248 related articles for article (PubMed ID: 28578922)
21. Predicting psychosis in a general adolescent psychiatric sample.
Lindgren M; Manninen M; Kalska H; Mustonen U; Laajasalo T; Moilanen K; Huttunen M; Cannon TD; Suvisaari J; Therman S
Schizophr Res; 2014 Sep; 158(1-3):1-6. PubMed ID: 25015028
[TBL] [Abstract][Full Text] [Related]
22. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services.
Foss-Feig JH; Velthorst E; Smith L; Reichenberg A; Addington J; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Keshavan M; Tsuang MT; Walker EF; Woods SW; Cannon TD; Bearden CE
J Am Acad Child Adolesc Psychiatry; 2019 Jun; 58(6):582-588. PubMed ID: 30797038
[TBL] [Abstract][Full Text] [Related]
23. Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia.
Lencz T; Smith CW; Auther A; Correll CU; Cornblatt B
Schizophr Res; 2004 May; 68(1):37-48. PubMed ID: 15037338
[TBL] [Abstract][Full Text] [Related]
24. The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning.
Brodey BB; Girgis RR; Favorov OV; Addington J; Perkins DO; Bearden CE; Woods SW; Walker EF; Cornblatt BA; Brucato G; Walsh B; Elkin KA; Brodey IS
Schizophr Res; 2018 Jul; 197():516-521. PubMed ID: 29358019
[TBL] [Abstract][Full Text] [Related]
25. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
[TBL] [Abstract][Full Text] [Related]
26. Course of clinical high-risk states for psychosis beyond conversion.
Michel C; Ruhrmann S; Schimmelmann BG; Klosterkötter J; Schultze-Lutter F
Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):39-48. PubMed ID: 28054132
[TBL] [Abstract][Full Text] [Related]
27. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.
Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
JAMA Psychiatry; 2018 Sep; 75(9):960-968. PubMed ID: 29971330
[TBL] [Abstract][Full Text] [Related]
28. Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis.
Schlosser DA; Campellone TR; Biagianti B; Delucchi KL; Gard DE; Fulford D; Stuart BK; Fisher M; Loewy RL; Vinogradov S
Schizophr Res; 2015 Dec; 169(1-3):204-208. PubMed ID: 26530628
[TBL] [Abstract][Full Text] [Related]
29. Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.
Fulford D; Pearson R; Stuart BK; Fisher M; Mathalon DH; Vinogradov S; Loewy RL
Psychiatry Res; 2014 Dec; 220(3):1077-83. PubMed ID: 25278477
[TBL] [Abstract][Full Text] [Related]
30. Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS).
Trotman HD; Holtzman CW; Walker EF; Addington JM; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen RK; Mathalon DH; Tsuang MT; Perkins DO; Seidman LJ; Woods SW; McGlashan TH
Schizophr Res; 2014 Dec; 160(1-3):104-9. PubMed ID: 25443665
[TBL] [Abstract][Full Text] [Related]
31. Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort.
Koutsouleris N; Worthington M; Dwyer DB; Kambeitz-Ilankovic L; Sanfelici R; Fusar-Poli P; Rosen M; Ruhrmann S; Anticevic A; Addington J; Perkins DO; Bearden CE; Cornblatt BA; Cadenhead KS; Mathalon DH; McGlashan T; Seidman L; Tsuang M; Walker EF; Woods SW; Falkai P; Lencer R; Bertolino A; Kambeitz J; Schultze-Lutter F; Meisenzahl E; Salokangas RKR; Hietala J; Brambilla P; Upthegrove R; Borgwardt S; Wood S; Gur RE; McGuire P; Cannon TD
Biol Psychiatry; 2021 Nov; 90(9):632-642. PubMed ID: 34482951
[TBL] [Abstract][Full Text] [Related]
32. Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study.
Walker EF; Trotman HD; Pearce BD; Addington J; Cadenhead KS; Cornblatt BA; Heinssen R; Mathalon DH; Perkins DO; Seidman LJ; Tsuang MT; Cannon TD; McGlashan TH; Woods SW
Biol Psychiatry; 2013 Sep; 74(6):410-7. PubMed ID: 23562006
[TBL] [Abstract][Full Text] [Related]
33. Family history of psychosis in youth at clinical high risk: A replication study.
Santesteban-Echarri O; Sandel D; Liu L; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Tsuang MT; Walker EF; Woods SW; Addington J
Psychiatry Res; 2022 May; 311():114480. PubMed ID: 35245743
[TBL] [Abstract][Full Text] [Related]
34. Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosis.
Santesteban-Echarri O; Liu L; Miller M; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Tsuang MT; Walker EF; Woods SW; Addington J
Schizophr Res; 2022 Oct; 248():114-121. PubMed ID: 36030758
[TBL] [Abstract][Full Text] [Related]
35. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
[TBL] [Abstract][Full Text] [Related]
36. Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome.
Carrión RE; Auther AM; McLaughlin D; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman L; Stone W; Tsuang M; Walker EF; Woods SW; Torous J; Cornblatt BA
Schizophr Res; 2021 Jan; 227():44-51. PubMed ID: 33131983
[TBL] [Abstract][Full Text] [Related]
37. Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project.
Salokangas RK; Heinimaa M; From T; Löyttyniemi E; Ilonen T; Luutonen S; Hietala J; Svirskis T; von Reventlow HG; Juckel G; Linszen D; Dingemans P; Birchwood M; Patterson P; Schultze-Lutter F; Ruhrmann S; Klosterkötter J;
Eur Psychiatry; 2014 Aug; 29(6):371-80. PubMed ID: 24315804
[TBL] [Abstract][Full Text] [Related]
38. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis.
Schlosser DA; Jacobson S; Chen Q; Sugar CA; Niendam TA; Li G; Bearden CE; Cannon TD
Schizophr Bull; 2012 Nov; 38(6):1225-33. PubMed ID: 21825282
[TBL] [Abstract][Full Text] [Related]
39. Anxiety in youth at clinical high risk for psychosis.
McAusland L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen R; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
Early Interv Psychiatry; 2017 Dec; 11(6):480-487. PubMed ID: 26456932
[TBL] [Abstract][Full Text] [Related]
40. Assessing depression in youth at clinical high risk for psychosis: a comparison of three measures.
DeVylder JE; Yang LH; Harkavy-Friedman JM; Azimov N; Walder DJ; Corcoran CM
Psychiatry Res; 2014 Feb; 215(2):323-8. PubMed ID: 24370335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
